Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Biomédica (Bogotá) ; 34(4): 589-597, oct.-dic. 2014. ilus, graf
Article in English | LILACS | ID: lil-730943

ABSTRACT

Introduction: Photodynamic therapy (PDT) using 5-aminolevulinic acid-induced protoporphyrin IX (ALA-PpIX) constitutes an interesting alternative for cutaneous leishmaniasis treatment. Objective: To evaluate the production of PpIXbased on the administration of ALA and MAL and the effect of ALA-PDTat cellular level on non-infected and infected THP-1 cells using Leishmania ( Viannia ) panamensis or Leishmania ( Leishmania ) infantum (syn Leishmania chagasi ) parasites. Materials and methods: Protoporphyrin IX (PpIX) production and mitochondrial colocalization were evaluated by confocal microscopy. Cell toxicities were evaluated after treatment with the compounds, followed by light irradiation (597-752 nm) at 2.5 J/cm 2 fluency using a colorimetric MTT assay for THP-1 cells and a standard microscopic analysis of parasites. Results were expressed as compound concentration activity against 50% of cells or parasites (CC 50 or IC 50 ). Results: ALA or MAL induced an endogenous PpIX with a red fluorescence localized mainly in the mitochondria inside human cells. ALA and MAL-PDT induced a similar range of toxicities on THP-1 cells (CC 50 0.16±0.01mM and 0.33±0.019 mM, respectively) without any apparent inhibition of intracellular parasites in the infected cells as compared to untreated controls. Exogenous PpIX-PDT was toxic to THP-1 cells (CC 50 0.00032±0.00002 mM), L. (L.) infantum (IC 50 0.003±0.0001 mM) and L. (V.) panamensis (IC 50 0.024±0.0001 mM) promastigotes. Conclusions: Despite the effectiveness of exogenous PpIX on promastigotes and the production of PpIX by human infected cells, treatment with ALA or MAL before irradiation was unable to completely destroy L. (L.) infantum or L. (V.) panamensis intracellular amastigotes.


Introducción. El tratamiento fotodinámico con ácido 5-aminolevulínico como inductor de la protoporfirina IX (ALA-PpIX) constituye una alternativa interesante en el tratamiento de la leishmaniasis cutánea. Objetivo. Evaluar la producción de protoporfirina IX (PpIX) a partir de la administración de ALA o MAL y el efecto de la PDT con ALA a nivel celular en células THP-1 no infectadas e infectadas con Leishmania ( Viannia ) panamensis o Leishmania ( Leishmania ) infantum (syn. Leishmania chagasi ). Materiales y métodos. La producción de protoporfirina IX y su ‘colocalización´ mitocondrial se evaluaron mediante microscopía ‘confocal´. Se evaluó la toxicidad celular después del tratamiento con los compuestos y la aplicación de irradiación de luz (597-752 nm) en una fluencia de 2,5 J/cm 2 mediante el empleo de la prueba colorimétrica con metil-tiazol-tetrazolio (MTT) en las células, y de métodos microscópicos estándar en los parásitos. Los resultados se expresaron como la concentración del compuesto activo en el 50 % de las células o parásitos (CC 50 o CI 50 ). Resultados. El ácido aminolevulínico o el metil-5-aminolevulinato indujeron la protoporfirina IX endógena en células humanas, y se observó fluorescencia de color rojo en las mitocondrias. La actividad del ácido aminolevulínico y del metil-5-aminolevulinato utilizados con terapia fotodinámica fue similar en las células THP-1 (CC 50 0,16±0,01 mM y 0,33±0,019 mM, respectivamente) y, aparentemente, no inhibió los parásitos en las células infectadas, en comparación con los controles. El tratamiento exógeno con protoporfirina IX y terapia fotodinámica fue tóxico para las células THP-1 (CC 50 0,00032 ±0,00002 mM) y para los promastigotes de L. (L .) infantum (IC 50 0,003±0,0001 mM) y L. ( V .) panamensis (CI 50 0,024±0,0001 mM). Conclusiones. A pesar de la ‘fotoactividad´ del tratamiento con protoporfirina IX en promastigotes y de su producción después del tratamiento con ácido aminolevulínico y metil-5-aminolevulinato en las células infectadas con Leishmania , no se observó daño en los amastigotes presentes en las células de L. ( L .) infantum o L . ( V .) panamensis .


Subject(s)
Humans , Aminolevulinic Acid/analogs & derivatives , Aminolevulinic Acid/pharmacology , Leishmania guyanensis/drug effects , Leishmania infantum/drug effects , Monocytes/drug effects , Photochemotherapy , Photosensitizing Agents/pharmacology , Protoporphyrins/analysis , Subcellular Fractions/drug effects , Aminolevulinic Acid/radiation effects , Amphotericin B/pharmacology , Cell Line, Tumor , Colorimetry , Leukemia, Monocytic, Acute/pathology , Lysosomes/chemistry , Microscopy, Fluorescence , Mitochondria/chemistry , Monocytes/parasitology , Monocytes/ultrastructure , Photosensitizing Agents/radiation effects , Species Specificity , Subcellular Fractions/chemistry
2.
São Paulo med. j ; 115(2): 1390-4, Mar.-Apr. 1997. ilus, tab
Article in English | LILACS | ID: lil-199907

ABSTRACT

Tamoxifen is an antiestrogen drug widely utilized for the adjuvant hormonal treatment of breast carcinoma. Its use in the primary prophylaxis of this disease is currently being proposed. Although the drug has few side effects, its precise action on breast tissue that has not undergone neoplastic transformation has not been fully elucidated. This prospective, randomized study assessed the estrogen activity of tamoxifen on the mammary gland epithelium of premenopausal patients using a quantitative analysis of mammary epithelium lysosomes identified by the cytochemical technique of GOMORI for acid phosphatase and by light microscopy. Tamoxifen significantly increased the number of lysosomes only during the secretory phase of the menstrual cycle. We concluded that the early effect of the drug on normal mammary tissue is synergistic with the effect of estrogen during the premenopausal period.


Subject(s)
Adult , Female , Humans , Adolescent , Tamoxifen/pharmacology , Breast/drug effects , Premenopause/drug effects , Estrogen Antagonists/pharmacology , Lysosomes/chemistry , Breast/ultrastructure , Breast Neoplasms/ultrastructure , Fibroadenoma/ultrastructure , Epithelial Cells , Menstrual Cycle/drug effects
3.
J Postgrad Med ; 1993 Oct-Dec; 39(4): 183-6
Article in English | IMSEAR | ID: sea-117256

ABSTRACT

A study on the functional ability of polymorphonuclear leucocytes (PMNL) indicates that the total lysosomal enzyme levels viz. Beta-glucuronidase, lysozyme, acid phosphatase and alkaline phosphatase were not altered in diabetics, compared to that in control subjects. However, the findings also reveal that the release of these lysosomal enzymes in response to a particulate stimulus is impaired in diabetics. This suggests that the bactericidal capacity of these cells, which are involved in phagocytosis, is impaired in diabetics, making them more vulnerable to infections.


Subject(s)
Adult , Case-Control Studies , Diabetes Complications , Female , Humans , Infections/etiology , Lysosomes/chemistry , Male , Neutrophils/chemistry , Phagocyte Bactericidal Dysfunction/blood , Recurrence
4.
Southeast Asian J Trop Med Public Health ; 1992 ; 23 Suppl 2(): 110-5
Article in English | IMSEAR | ID: sea-35730

ABSTRACT

Liver tissues from 17 patients with advanced stages of beta-thal/Hb E disease were examined by light and electron microscopy, with emphasis on cellular damage due to excess iron overload. Various histochemical stains were performed to grade degrees of iron deposition and fibrosis, and to demonstrate hepatitis B surface antigen, in Kupffer cells as well as macrophages. The results of light and electron microscopic studies were correlated. There was a variation in the distribution of hepatic iron and the severity of fibrosis. In most of the cases ballooning degeneration of the hepatocytes, increase in number of lysosomes, hemosiderin and ferritin in hepatocytes as well as in the sinusoidal lining cells were found. The ferro-acidophilic body, representing another important form of hepatocellular necrosis also occurred. So far no precise mechanisms can be concluded.


Subject(s)
Adolescent , Adult , Biopsy , Female , Ferritins/chemistry , Hemoglobin E , Hemoglobinopathies/complications , Hemosiderosis/epidemiology , Hepatitis B Surface Antigens/chemistry , Hospitals, University , Humans , Hyperplasia , Hypertrophy , Kupffer Cells/pathology , Liver Cirrhosis/epidemiology , Lysosomes/chemistry , Macrophages/pathology , Male , Microscopy, Electron , Middle Aged , Severity of Illness Index , Thailand/epidemiology , beta-Thalassemia/complications
5.
Rev. chil. obstet. ginecol ; 56(5): 359-63, 1991. tab
Article in Spanish | LILACS | ID: lil-111747

ABSTRACT

Los autores cuantificaron los lisosomas del epitelio de la trompa uterina de mujeres en los períodos menstruales y en la postmenopausia tratadas o no, con estrógenos conjugados durante 21 días. Para esto, fragmentos de la ampolla uterina fueron retirados, fijados y sometidos con el método citoquímico para la detección de la fosfatasa ácida. Los resultados mostraron ser, que el número de lisosomas en la fase proliferativa era significativamente mayor que en la fase secretora o en la postmenopausia. El número de lisosomas en la postmenopausia se muestran significativamente mayor en las mujeres tratadas con estrógenos conjugados. Nuestros resultados indican que los estrogenos son los responsables por el aumento del número de lisosomas


Subject(s)
Humans , Female , Adult , Middle Aged , Fallopian Tubes/chemistry , Lysosomes/chemistry , Menopause , Menstrual Cycle , Estrogen Replacement Therapy/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL